Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
The binding of a ligand to its receptor has always been viewed as the trigger for signal transduction to ensue. However, as Golstein explains in his Perspective, new findings (Chan et al. and Siegel et al.) suggest that the Fas receptor preassembles into trimers without the help of its ligand, and that this preassembly conditions ligand binding, and thus subsequent signal transduction of a death signal.
The author is at the Centre d'Immunologie INSERM-CNRS de Marseille-Luminy, Case 906, 13288 Marseille Cedex 9, France. E-mail: golstein{at}ciml.univ-mrs.fr
The editors suggest the following Related Resources on Science sites:
In Science Magazine
REPORTS
Francis Ka-Ming Chan, Hyung J. Chun, Lixin Zheng, Richard M. Siegel, Kimmie L. Bui, and Michael J. Lenardo (30 June 2000) Science288 (5475), 2351.
[DOI: 10.1126/science.288.5475.2351] |Abstract »|Full Text »|PDF »
REPORTS
Richard M. Siegel, John K. Frederiksen, David A. Zacharias, Francis Ka-Ming Chan, Michele Johnson, David Lynch, Roger Y. Tsien, and Michael J. Lenardo (30 June 2000) Science288 (5475), 2354.
[DOI: 10.1126/science.288.5475.2354] |Abstract »|Full Text »|PDF »
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
A Role for the Fas/FasL System in Modulating Genetic Susceptibility to T-Cell Lymphoblastic Lymphomas.
M. Villa-Morales, J. Santos, E. Perez-Gomez, M. Quintanilla, and J. Fernandez-Piqueras (2007)
Cancer Res.
67, 5107-5116
|Abstract »|Full Text »|PDF »
A homozygous Fas ligand gene mutation in a patient causes a new type of autoimmune lymphoproliferative syndrome.
M. Del-Rey, J. Ruiz-Contreras, A. Bosque, S. Calleja, J. Gomez-Rial, E. Roldan, P. Morales, A. Serrano, A. Anel, E. Paz-Artal, et al. (2006)
Blood
108, 1306-1312
|Abstract »|Full Text »|PDF »
Role of membrane sphingomyelin and ceramide in platform formation for Fas-mediated apoptosis.
M. Miyaji, Z.-X. Jin, S. Yamaoka, R. Amakawa, S. Fukuhara, S. B. Sato, T. Kobayashi, N. Domae, T. Mimori, E. T. Bloom, et al. (2005)
J. Exp. Med.
202, 249-259
|Abstract »|Full Text »|PDF »
Regulation of Lymphocyte Apoptosis by Interferon Regulatory Factor 4 (IRF-4).
J. C. Fanzo, C.-M. Hu, S. Y. Jang, and A. B. Pernis (2003)
J. Exp. Med.
197, 303-314
|Abstract »|Full Text »|PDF »
Tumor Necrosis Factor Receptor 1 Is an ATPase Regulated by Silencer of Death Domain.
Differential Secretion of Fas Ligand- or APO2 Ligand/TNF-Related Apoptosis-Inducing Ligand-Carrying Microvesicles During Activation-Induced Death of Human T Cells.
I. Monleon, M. J. Martinez-Lorenzo, L. Monteagudo, P. Lasierra, M. Taules, M. Iturralde, A. Pineiro, L. Larrad, M. A. Alava, J. Naval, et al. (2001)
J. Immunol.
167, 6736-6744
|Abstract »|Full Text »|PDF »
Natural Ceramide Reverses Fas Resistance of Acid Sphingomyelinase-/- Hepatocytes.
F. Paris, H. Grassme, A. Cremesti, J. Zager, Y. Fong, A. Haimovitz-Friedman, Z. Fuks, E. Gulbins, and R. Kolesnick (2001)
J. Biol. Chem.
276, 8297-8305
|Abstract »|Full Text »|PDF »
Ceramide Enables Fas to Cap and Kill.
A. Cremesti, F. Paris, H. Grassme, N. Holler, J. Tschopp, Z. Fuks, E. Gulbins, and R. Kolesnick (2001)
J. Biol. Chem.
276, 23954-23961
|Abstract »|Full Text »|PDF »